Objective: To evaluate the influence of maternal smoking on antioxidative capacity and intensity of oxidative damage in breast milk.
Introduction
The evidence for beneficial effects of breast milk is long standing and abundant, nonetheless research is still uncovering new data that supports breastfeeding. Aside from having a high nutritional value and supporting the immune function, human breast milk also possesses antioxidant properties. Physiological functions of antioxidant barrier include the deactivation and scavenging of reactive oxygen species. Reactive oxygen species are involved in the processes of carcinogenesis, aging and chronic inflammation. They are also implicated in critical diseases connected with prematurity, such as bronchopulmonary dysplasia, retinopathy and necrotic enterocolitis. 1 The antioxidant systems that protect the human body are comprised of both endogenous and exogenous components, the latter of which are supplied with the diet. This antioxidant barrier includes enzymes as well as non-enzymatic components. Human breast milk contains either non-enzymatic antioxidants (among others coenzyme Q, lactoferrin and vitamins A, E and C) [2] [3] [4] [5] or antioxidant enzymes. 6, 7 In vitro, human breast milk antioxidants were observed to decrease hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. 3, 4 Antioxidant properties of human breast milk support the natural antioxidant barrier of neonates and infants. Lower levels of oxidative stress are observed in breastfed infants when compared with those receiving infant formulas, 8, 9 including the antioxidant-enriched formulas. Natural breastfeeding has been found to lower oxidative stress in neonates, not only in healthy full-term newborns but also in newborns with very low-birth weight, who are particularly endangered to the consequences of oxidative stress. 5 The efficiency of antioxidant barrier is modulated by many factors including gender, age, place of residence, dietary intake, obesity and smoking. 10 Marked abnormalities of blood antioxidant concentrations were reported from smokers resulting in decreased antioxidative capacity of blood. 10 Besides causing significant disruption of the antioxidant barrier, smoking also enhances oxidative stress. Higher concentrations of oxidatively damaged proteins and lipids are observed in smokers due to a higher intensity of reactive oxygen species-mediated reactions.
6,11 Concentration of isoprostanes (products of nonenzymatic oxidation of arachidonic acid) is one of the reliable biomarkers of oxidative stress intensity in vivo.
12
Maternal smoking is often observed during pregnancy and lactation, and some women return to smoking right after delivery despite pregnancy related cessation. The evidence of the effects of maternal smoking during lactation on the pro-oxidantantioxidant barrier is sparse. Therefore, the aim of this study was to evaluate the influence of maternal smoking on antioxidative capacity and intensity of oxidative damage in human breast milk.
Methods

Participants
This study was conducted between September 2006 and January 2007 at two hospital units in Gdansk (Northern Poland): Obstetrical Ward of the Voivodeship Specialist Hospital, and the Obstetrical Ward at the Institute of Obstetrics and Gynecology, Medical University of Gdansk. The study group (Group I, n ¼ 30) was comprised of postpartum women and their newborns. The inclusion criteria were as follows: normal spontaneous full term delivery, neonates in good general status with normal birth weight. All participants declared smoking more than five cigarettes per day during pregnancy. The exclusion criteria included passive smoking, acute and chronic disorders (including gestational diabetes) and pharmacotherapy other than with vitamin supplementation. Control group (Group II, n ¼ 29) was comprised of postpartum women and their newborns who met all of these aforementioned inclusion criteria with the exception of smoking during pregnancy.
All the procedures were approved by the Local Ethics Committee of the Medical University in Gdansk. The subjects gave their informed consent before the start of any procedure.
Colostrum and mature milk samples Colostrum samples were collected on the third day after delivery. The mammary gland was evacuated completely with an aid of electric lactator 2 h after the first morning feeding (between 0500 and 0800 hours). The colostrum was collected into sterile glass containers. Immediately after collection and careful mixing, 5 ml samples were taken, placed into another sterile container and immediately frozen at À80 1C. The remaining colostrum was fed to the infants. Breast milk samples (10 ml) were collected between the 30th and the 32nd day after delivery and treated in the same way.
Urine samples
Morning maternal and neonatal urine samples were obtained on the day of the mature milk sampling. The samples were placed in plastic containers and frozen at À80 1C until analysis.
Isoprostane determination
Isoprostane concentrations in colostrum/mature milk and urine were determined with commercially available kits: STAT 8-Isoprostane EIA kit (Cayman Chemical, Ann Arbor, MI, USA) and Bioxytech Urinary 8-epi-Prostaglandin F 2a Enzyme Immunoassay for Urinary Isoprostane (Oxis Research, Beverly Hills, CA, USA), respectively. 13 Determination of 8-isoprostane in breast milk samples included three stages: (1) sample preparation, (2) solid phase extraction of 8-isoprostanes (8-Isoprostane Affinity Column, Cayman Chemical) and (3) immunoenzymatic measurement with the STAT-8-Isoprostane EIA Kit (Cayman Chemical). During the first stage, milk samples were diluted five times with the Affinity Buffer (Cayman Chemical) and centrifuged in order to remove the lipid fraction. Subsequently, clear breast milk solution was introduced into the column prepared for 8-isoprostane extraction. The extraction was carried out according to the instructions provided by the column manufacturer, using the Baker spe-12G vacuum extraction system (JT Baker, London, UK). Ethanol solution of 8-isoprostanes was obtained as a final product and evaporated to dryness under nitrogen stream at room temperature. Total solids were dissolved in 150 ml of Tris and used for 8-isoprostane determination on immunoassay.
Immunoassay with STAT-8-Isoprostane EIA Kit was carried out as per the manufacturer's instructions. The absorbance was measured in triplicate at 405 nm wavelength with an aid of Bio-Tek FL600 plate reader with KC4 software (BIO-TEK Instruments, Winooski, VT, USA). Concentration of 8-isoprostanes was read from the calibration curve that was obtained during the test.
Determination of 8-isoprostane concentrations in maternal and neonatal urine samples included two stages: (1) sample preparation, and (2) immunoenzymatic measurement with the Bioxytech Urinary 8-epi-Prostaglandin F 2a Enzyme Immunoassay for Urinary Isoprostane (Oxis Research). During the first stage, urine samples were thawed and centrifuged, and clear solution was applied to the test microplate. Bioxytech Urinary 8-epi-Prostaglandin F 2a Enzyme Immunoassay for Urinary Isoprostane was carried out following the protocol provided by the manufacturer. The absorbance was measured in triplicate at 450 nm wavelength with Bio-Tek FL600 microplate reader with KC4 software (BIO-TEK Instruments). Concentration of 8-isoprostane was read from calibration curve that was prepared using 8-epi-Prostaglandin F 2a standard solutions.
Total antioxidant status (TAS)
Colostrum or mature milk samples were centrifuged for 10 min at 5000 r.p.m. The supernatant was collected and the remaining fluid was further centrifuged in the same conditions. Final fluid product was diluted 20-times with distilled water and used for further analysis. TAS was determined by Rice-Evans and Miller method 14 with an aid of commercially available reagent kit (Randox, Crumlin, UK). In this method, incubation of ABTS (2,2 0 -azino-bis-(3-ethylbenzthiazoline sulphonate)) with peroxidase and hydrogen Antioxidative status of breast milk M Zagierski et al superoxide leads to the formation of blue-green-colored cationic radical ABTS 0. A decrease in the color intensity of this radical can be observed when antioxidants are present within analyzed sample. This decline in color intensity was measured spectrophotometrically (LKB-Ultrospec III) at 600 nm wavelength. The results were presented in mmol l À1 .
Urinary cotinine
The urinary concentration of creatinine was measured with a standard method based on Jaffe's reaction. 15 Urinary cotinine was determined with an aid of cotinine (Urine) ELISA (EIA-1377 or EIA-1726, DRG International, Mountain Side, NJ, USA). Akin to the previous studies, 16 cotinine-to-creatinine ratio equal to 150 ng of cotinine per mg of creatinine was considered a cutoff value for distinguishing active smoking.
Statistical analysis
Normal distribution of continuous variables was tested with the Kolmogorow-Smirnov test. Depending on distribution, the results were presented as arithmetic means and their s.d. or medians and confidence intervals. Arithmetic means between Group I and II were compared with the Student's t-test for independent variables or the Mann-Whitney test whereas colostrum and mature milk parameters were compared with the Wilcoxon test. Associations between continuous variables were tested with Spearman's rank coefficient (R). Calculations were performed using Statistica 8 (StatSoft, Warsaw, Poland) software and R 2.6.1 statistical environment, with statistical significance defined as Pp0.05.
Results
Characteristics of study participants and their neonates are summarized in Table 1 . In all women from Group I, declared smoking was confirmed by the urinalysis of cotinine concentration.
Colostrum TAS in smokers was significantly lower than in nonsmokers. In both groups, the TAS of mature milk was higher compared with colostrum, but significant differences were observed amongst smokers only (Table 2) . No significant differences were observed between smoking and non-smoking mothers in terms of isoprostane concentrations in colostrum and mature milk. In smokers, however, the isoprostane concentration of mature milk was significantly higher than the colostrum concentration (Table 2) .
Maternal urinary isoprostane concentrations were higher in the smoking group than in non-smokers but these differences were not significant (Table 3 ).
Significant inverse correlation between maternal urinary isoprostane concentration and the TAS of mature breast milk was observed in smokers (R ¼ -0.525, P ¼ 0.023), but not in nonsmokers (R ¼ 0.161, P ¼ 0.422).
Discussion
In addition to the many documented detrimental health consequences of tobacco smoke to the mother and fetus/neonate, Antioxidative status of breast milk M Zagierski et al maternal smoking during pregnancy and lactation affects the pro-oxidant-antioxidant balance of the body. In this study, we analyzed the effects that smoking during pregnancy and lactation has on the levels of the markers for oxidative lipid damage in mothers and neonates, as well as in breast milk from various periods of lactation (colostrum and mature milk). Moreover, we analyzed the effects of maternal smoking on the antioxidant properties of human breast milk.
To our best knowledge, published research of the TAS of breast milk from smokers is quite sparse. The only available study is by Ermis et al., 7 and it did not reveal any significant differences in the antioxidant potential of breast milk from smokers and non-smokers obtained on the 7th day of lactation. Similarly to our preliminary studies, 17 it revealed that colostrum (3rd day of lactation) from mothers who have been smoking during pregnancy has significantly lower TAS compared with colostrum from non-smokers. Furthermore, a tendency for lower TAS values in mature milk of smokers was found, but this difference was insignificant when compared with non-smoking mothers.
Moreover, our study confirmed previously discovered evidence of decreased concentrations of particular components of antioxidant barrier (including vitamin E and C) in breast milk of smoking mothers. [18] [19] [20] Importantly, this study revealed inferior antioxidant properties of breast milk from smoking mothers. This finding substantiates further research on the effects of inferior antioxidant properties of breast milk on the health status of infants born to smoking mothers. It is particularly important in view of fact that both the TAS [21] [22] [23] and concentrations of various antioxidants such as vitamins E and A, and b-carotene 18,21,24 -26 in the umbilical cord blood of these neonates were significantly lower compared with the non-smokers.
Because breast milk is the source of numerous compounds that support the neonate's and infant's antioxidant barrier, the evidence of its antioxidant properties seems particularly important. According to Aycicek et al., 8 both TAS and blood concentrations of such antioxidants as uric acid, albumin and vitamin C in breastfed infants are higher than in children receiving infant formulas.
At birth, neonates are exposed to enhanced oxidative stress. Even in these newborns that are born following a physiological delivery, the intensity of oxidative stress is initially high and then decreases gradually during uncomplicated puerperium. 27 Higher intensity of oxidative stress is typically reported from breasted children. 5, 28 The results of this study suggest that positive effects of breastfeeding on the pro-oxidant-antioxidant balance may be compromised by maternal smoking during lactation. This finding is particularly important in view of the fact that many women who successfully refrained from smoking during pregnancy return to this habit immediately after the delivery.
Previous studies revealed that women who smoked during pregnancy were characterized by lower levels of TAS along with decreased concentrations of such antioxidants as uric acid and vitamins A and C. [21] [22] [23] Interestingly, the disorders of antioxidative barrier were also observed in passive smokers. 23 However, the results of published research on the levels of markers for free radical-mediated damage of proteins and lipids (considered as a measure of oxidative stress intensity) in women smoking during pregnancy are inconclusive. Argü elles et al. 21 observed higher serum concentrations of lipid hydroperoxides and protein carbonyl groups in smoking pregnant women. However, other authors did not confirm any smoking-related differences in the concentrations of malondialdehyde, a lipid peroxidation marker, in pregnant women. 7, 23 This is consistent with the results of our study which revealed no significant smoking-related differences in urinary isoprostane concentration. However, our study revealed a significant inverse correlation between maternal urinary isoprostane concentration and breast milk TAS on 30th day of lactation, while a similar relationship was not observed amongst non-smoking mothers. This finding suggests that increasing levels of oxidative stress in smoking mothers are reflected by worse antioxidant properties of breast milk. Decreased concentrations of antioxidants in mature breast milk may result from the depletion of the protective antioxidant mechanisms that occur during enhanced oxidative stress in smokers.
Little is known about the oxidative changes in breast milk components. The only research published thus far has revealed that smoking mothers have higher breast milk concentrations of malondialdehyde, while no significant differences in blood malondialdehyde are observed between smokers and non-smokers. 7 In this study we did not observe significant differences in isoprostane (lipid peroxidation marker) concentrations in breast milk of smoking and non-smoking mothers. Paradoxically, isoprostane concentrations were the lowest in colostrum from Antioxidative status of breast milk M Zagierski et al smoking mothers. Probably, this phenomenon was associated with at least partial maternal abstinence from smoking during perinatal period, for example, due to administrative regulations (such as smoking prohibition in the hospital wards). Significant increase in isoprostane concentrations observed in this study in smoking mothers' mature breast milk seems to support this hypothesis.
In conclusion, maternal smoking triggers harmful effects not only directly via negative influence of cigarette smoke on an infant, but also indirectlyFby impairing pro-oxidant-antioxidant balance of breast milk. Further studies of antioxidant barrier disorders and free-radical-mediated changes in breast milk nutrients seem required and essential in the prevention of harmful effects for infants and neonates. Additionally, further research is needed in order to determine the potential indications for antioxidant supplementation in women who smoke during lactation or in their offspring.
